Audiologists in Timonium, MD Accepting Medicare

3 Audiologists found. Showing 1 - 3

Mrs. Aimee B Kaplan, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 2147 York Rd, Timonium, MD 21093 Phone: 410-252-3100    Fax: 866-852-6483

Nikita Razeghi, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 22 W Padonia Rd Ste C245, Timonium, MD 21093 Phone: 410-252-9270    Fax: 410-252-9270

The Hearing Wellness Center Llc Audiologist Medicare: Medicare Enrolled Practice Location: 2331 York Rd Ste 102, Timonium, MD 21093 Phone: 410-409-1010

News Archive

Lancaster psychologist helps NHS oncology staff to remain healthy during COVID-19 crisis

A Lancaster psychologist is part of a UK team researching staff who work in oncology departments to share their experiences and views about working during the COVID-19 crisis.

Study may provide novel targetable mechanisms of therapeutic resistance to anti-VEGF therapies

To establish a molecular signature of this resistance in ovarian cancer, the authors developed preclinical tumor models of adaptive resistance to chronic anti-VEGF treatment.

Ketogenic diet prolongs life and improves memory and physical functions in aged mice find researchers

A pair of new studies find that diets termed ketogenic that are classically low in carbohydrates can prolong life in adult male laboratory mice. In addition this ketogenic diet also preserves the memory functions as well as muscle masses of the aged mice that were fed on it. The mechanism behind this could be the fact that ketogenic diet induces protein acetylation in the mice liver and muscles.

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.

Study provides better glimpse at the biology of height

The largest genome-wide association study (GWAS) to date, involving more than 300 institutions and more than 250,000 subjects, roughly doubles the number of known gene regions influencing height to more than 400.

Read more Medical News

› Verified 1 days ago